CINECA IRIS Institutional Research Information System

VIGNANI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.050
AS - Asia 2.605
EU - Europa 2.445
SA - Sud America 256
Continente sconosciuto - Info sul continente non disponibili 226
OC - Oceania 145
AF - Africa 99
Totale 9.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.814
CN - Cina 1.025
IT - Italia 574
SG - Singapore 537
GB - Regno Unito 291
JP - Giappone 262
DE - Germania 235
FR - Francia 175
CA - Canada 162
BR - Brasile 155
VN - Vietnam 145
IE - Irlanda 133
AU - Australia 131
SE - Svezia 126
IN - India 122
FI - Finlandia 117
ES - Italia 116
AT - Austria 109
UA - Ucraina 103
HK - Hong Kong 102
PL - Polonia 76
KR - Corea 71
TW - Taiwan 68
NL - Olanda 66
TR - Turchia 54
BE - Belgio 47
CH - Svizzera 43
ID - Indonesia 42
GR - Grecia 40
MX - Messico 38
PT - Portogallo 30
RU - Federazione Russa 30
DK - Danimarca 28
AR - Argentina 25
CO - Colombia 25
IQ - Iraq 25
CL - Cile 23
IL - Israele 23
TH - Thailandia 18
BD - Bangladesh 17
ZA - Sudafrica 17
IR - Iran 16
RO - Romania 16
EG - Egitto 14
NZ - Nuova Zelanda 14
PH - Filippine 14
RS - Serbia 14
MA - Marocco 13
NO - Norvegia 13
PK - Pakistan 13
EC - Ecuador 12
HR - Croazia 12
KE - Kenya 12
GH - Ghana 10
LB - Libano 10
LT - Lituania 10
MY - Malesia 10
HU - Ungheria 9
EU - Europa 8
JM - Giamaica 8
SK - Slovacchia (Repubblica Slovacca) 8
TN - Tunisia 7
MO - Macao, regione amministrativa speciale della Cina 6
NG - Nigeria 6
NI - Nicaragua 6
PE - Perù 6
SI - Slovenia 6
CZ - Repubblica Ceca 5
HN - Honduras 5
VE - Venezuela 5
GT - Guatemala 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
BJ - Benin 3
CR - Costa Rica 3
CY - Cipro 3
KZ - Kazakistan 3
LV - Lettonia 3
LY - Libia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CG - Congo 2
CU - Cuba 2
JO - Giordania 2
LC - Santa Lucia 2
MT - Malta 2
NE - Niger 2
PR - Porto Rico 2
SA - Arabia Saudita 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
Totale 9.593
Salva come PNG Salva come JPEG
Città #
Singapore 294
Ashburn 271
Beijing 269
Chandler 232
Santa Clara 198
Redwood City 197
Fairfield 177
San Jose 166
Houston 124
Dublin 120
Wilmington 113
Woodbridge 108
Seattle 102
Shanghai 99
Vienna 93
Tokyo 91
Torino 72
Helsinki 71
Pisa 70
Guangzhou 68
Nyköping 68
Cambridge 63
Milan 59
London 58
Jacksonville 56
Ann Arbor 54
Chengdu 48
Los Angeles 43
Hong Kong 42
Munich 41
Warsaw 41
Nanjing 40
Villeurbanne 40
Dong Ket 39
Council Bluffs 38
Taipei 35
New York 34
Dallas 33
Lauterbourg 32
Medford 32
Princeton 31
Wuhan 30
Boston 29
Chicago 29
Hanoi 29
Ho Chi Minh City 29
Turin 29
São Paulo 27
Columbus 26
Duncan 26
Toronto 25
Jakarta 24
The Dalles 24
Rome 23
Athens 20
Binbrook 20
Dearborn 20
Hangzhou 20
Philadelphia 20
Bengaluru 19
Brisbane 19
Changsha 19
Jinan 19
Sydney 19
Buffalo 18
Kalundborg 18
Seoul 18
Raritan 17
Hefei 16
Paris 16
Peoria 16
San Diego 16
Shenyang 16
Turku 16
Düsseldorf 15
Fremont 15
Québec 15
Santiago 15
Zhengzhou 15
Atlanta 14
Central District 14
Manchester 14
Phoenix 14
Surrey 14
Adelaide 13
Frankfurt am Main 13
Madrid 13
Redondo Beach 13
Tianjin 13
Barcelona 12
Brussels 12
Kunming 12
Montréal 12
Orem 12
Zurich 12
Berlin 11
Chongqing 11
Istanbul 11
Melbourne 11
New Delhi 11
Totale 4.911
Salva come PNG Salva come JPEG
Nome #
Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer 1.368
Addition of docetaxel to androgen deprivation therapy for patients with hormone-sensitive metastatic prostate cancer: A systematic review and meta-analysis 1.350
Hormonal treatment and quality of life of prostate cancer patients: new evidences 948
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer 680
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer 603
Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer 471
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis 460
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome 356
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 245
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 228
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 220
C28Sequencing cabazitaxel and new generation hormonal treatments in metastatic castration resistant prostate cancer patients after first line docetaxel: a retrospective analysis 210
Immunotherapy for patients with advanced urothelial cancer: Current evidence and future perspectives 188
Immediate or delayed nephrectomy in patients with metastatic renal cancer who are receiving targeted agents: Is the analysis at risk for guarantee- time bias? 187
Enzalutamide-resistant castration-resistant prostate cancer: Challenges and solutions 176
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer 171
Rediscovering secondary tumors of the prostate in the molecular era 152
LATITUDE and other coordinates in quality of life of prostate cancer patients 148
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. 143
Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients 139
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives 130
Metastatic castration-resistant prostate cancer: Time for innovation 128
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel 127
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients’ quality of life 127
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel 124
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 112
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 111
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis 100
Prognostic role of early PSa drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide 89
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications 85
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis 84
Evaluation of cognitive function in trials testing new-generation hormonal therapy in patients with prostate cancer: A systematic review 83
Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. 74
Prognostic value of systemic inflammatory markers in avelumab maintenance for advanced urothelial carcinoma: the multicentric SAILOR analysis 9
Totale 9.826
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022722 0 0 61 62 56 39 68 46 51 85 181 73
2022/2023980 55 105 46 89 98 178 61 68 125 40 76 39
2023/2024745 67 79 44 55 66 89 69 58 20 55 71 72
2024/20251.184 49 82 81 95 245 90 57 56 110 96 85 138
2025/20261.757 188 60 105 187 163 114 275 81 153 123 82 226
2026/2027224 76 107 41 0 0 0 0 0 0 0 0 0
Totale 9.826